Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
Jean-Paul Clozel, CEO Actelion - snbchf.com
Sanofi Reportedly in Talks to Buy Actelion Pharmaceuticals After Johnson & Johnson Backs Out of Negotiations
How is Actelion Spin-Off Idorsia Doing One Year Later?
Jean-Paul Clozel - Crunchbase Person Profile
Actelion-CEO Jean Paul-Clozel - Der Kapitän geht noch nicht von Bord - News - SRF
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Abspaltung von Actelion heisst Idorsia - FM1Today
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Jean-Paul Clozel
Actelion-Gründer ausgezeichnet – Berührende Würdigung eines Erfolgs-Teams | Basler Zeitung
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Tages-Anzeiger
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Stock ...
Jean-Paul und Martine Clozel: Ärzte ohne Grenzen | BILANZ
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Actelion-CEO: «Aktie wird weiter steigen» | cash
Anerkennungspreis für eine Starke Region 2021 an Martine und Jean-Paul Clozel und Walter Fischli – Vereinigung für eine starke Region
PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland
After split from Actelion, Idorsia CEO plans to raise more cash in 2019 | Reuters
Jean-Paul Clozel | EY - Global
Actelion Could Boost Takeover Price for Johnson & Johnson
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
Ein schweres Erbe für Jean-Paul Clozel | NZZ
